Browse Pet Safety Reports
16,698 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,698 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,698 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Apr 3, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Apr 3, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Closure, Abnormal; Dispenser, Abnormal; Dif... | Recovered/Normal |
| Apr 3, 2019 | Human | Unknown | Ivermectin | Joint pain; Tiredness; Blistering (see also Application site SOC) | Outcome Unknown |
| Apr 3, 2019 | Human | Unknown | Tulathromycin | Puncture wound; Injection site pain | Outcome Unknown |
| Apr 2, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Product problem; Accidental exposure; Tubes... | Ongoing |
| Apr 2, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Accidental exposure | Ongoing |
| Apr 2, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Outcome Unknown |
| Apr 1, 2019 | Human | Unknown | Florfenicol; Terbinafine Hydrochlorid... | Erythema (for urticaria see Immune SOC); Burning sensation of eye; Skin irrit... | Recovered/Normal |
| Apr 1, 2019 | Human | Unknown | Tylosin | Injection site swelling | Recovered/Normal |
| Apr 1, 2019 | Human | Unknown | Maropitant Citrate | Eye irritation; Mouth irritation | Outcome Unknown |
| Apr 1, 2019 | Human | Unknown | Imidacloprid; Moxidectin | Taste alteration; Localised numbness (see also application site SOC); Tinglin... | Outcome Unknown |
| Apr 1, 2019 | Human | Unknown | Melarsomine Dihydrochloride | Injection site swelling; Injection site pain | Outcome Unknown |
| Apr 1, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Tubes, Leaking; Accidental exposure | Ongoing |
| Mar 29, 2019 | Human | Unknown | Florfenicol | Chest tightness; Thoracic pain | Recovered/Normal |
| Mar 29, 2019 | Human | Unknown | Ceftiofur Hydrochloride | Localised numbness (see also application site SOC); Localised pain NOS (see o... | Outcome Unknown |
| Mar 29, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Difficulty of Use; Accidental exposure | Ongoing |
| Mar 29, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Mar 29, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Accidental exposure | Ongoing |
| Mar 29, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Diarrhoea | Ongoing |
| Mar 29, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Dispenser, Abnormal | Ongoing |
| Mar 28, 2019 | Human | Unknown | Tulathromycin | Puncture wound | Outcome Unknown |
| Mar 27, 2019 | Human | Unknown | Selamectin | Localised itching; Blotchy rash; Generalised itching; Generalised rash | Recovered/Normal |
| Mar 27, 2019 | Human | Unknown | Doramectin | Injection site bleeding; Abrasion | Outcome Unknown |
| Mar 27, 2019 | Human | Unknown | Tulathromycin | Injection site pain | Recovered/Normal |
| Mar 27, 2019 | Human | Unknown | Tilmicosin | Bad taste; Accidental exposure | Recovered/Normal |
| Mar 27, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Product problem; Containers, Leaking; Accid... | Recovered/Normal |
| Mar 26, 2019 | Human | Unknown | Selamectin | Bad taste; Accidental exposure | Outcome Unknown |
| Mar 23, 2019 | Human | Unknown | Florfenicol; Terbinafine; Betamethasone | Eye disorder NOS (for photophobia see 'neurological') | Outcome Unknown |
| Mar 22, 2019 | Human | Unknown | Maropitant Citrate | Immediate pain upon injection | Outcome Unknown |
| Mar 22, 2019 | Human | Unknown | Selamectin | Localised pain NOS (see other 'SOCs' for specific pain); Application site bur... | Recovered/Normal |
| Mar 22, 2019 | Human | Unknown | Altrenogest Oily Solution | Vomiting; Diarrhoea; Fever; Headache | Ongoing |
| Mar 21, 2019 | Human | Unknown | Neomycin Sulfate; Thiabendazole; Dexa... | Burning sensation of eye | Recovered/Normal |
| Mar 20, 2019 | Human | Unknown | Ractopamine Hydrochloride | Hyperactive | Outcome Unknown |
| Mar 20, 2019 | Human | Unknown | Enrofloxacin | Injection site lesion | Recovered/Normal |
| Mar 19, 2019 | Human | Unknown | Tilmicosin | Tingling sensation; Accidental exposure; Tongue paraesthesia | Recovered/Normal |
| Mar 18, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Containers, Leaking; Dispenser, Abnormal | Recovered/Normal |
| Mar 18, 2019 | Human | Unknown | Moxidectin | Injection site pain; Injection site reaction NOS | Outcome Unknown |
| Mar 16, 2019 | Human | Unknown | Tulathromycin | Injection site swelling; Injection site pain; Injection site bruising; Inject... | Ongoing |
| Mar 16, 2019 | Human | Unknown | Bupivacaine Lipsome Injectable Suspen... | Eye irritation; Conjunctivitis | Outcome Unknown |
| Mar 15, 2019 | Human | Unknown | Mirtazapine | Headache | Outcome Unknown |
| Mar 15, 2019 | Human | Unknown | Ivermectin; Pyrantel As Pamoate Salt | Hives (see also 'Skin'); Pruritus | Recovered/Normal |
| Mar 13, 2019 | Human | Unknown | Ketamine Hydrochloride | Burning sensation of eye; Eye redness | Recovered/Normal |
| Mar 12, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Mar 11, 2019 | Human | Unknown | Imidacloprid; Moxidectin | Application site reaction NOS | Outcome Unknown |
| Mar 11, 2019 | Human | Unknown | Tiletamine Hcl;Zolazapam Hcl | Eye irritation | Recovered/Normal |
| Mar 11, 2019 | Human | Unknown | Selamectin | Eye tingling | Recovered/Normal |
| Mar 9, 2019 | Human | Unknown | Enrofloxacin | Dizziness; Injection site nodule; Injection site numbness; Injection site bru... | Recovered/Normal |
| Mar 9, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Diarrhoea; Stomach upset | Ongoing |
| Mar 8, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Mar 8, 2019 | Human | Unknown | Lotilaner | Cough; Excess tear flow | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.